Literature DB >> 11890313

Dose finding using the biased coin up-and-down design and isotonic regression.

Mario Stylianou1, Nancy Flournoy.   

Abstract

We are interested in finding a dose that has a prespecified toxicity rate in the target population. In this article, we investigate five estimators of the target dose to be used with the up-and-down biased coin design (BCD) introduced by Durham and Flournoy (1994, Statistical Decision Theory and Related Topics). These estimators are derived using maximum likelihood, weighted least squares, sample averages, and isotonic regression. A linearly interpolated isotonic regression estimate is shown to be simple to derive and to perform as well as or better than the other target dose estimators in terms of mean square error and average number of subjects needed for convergence in most scenarios studied.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890313     DOI: 10.1111/j.0006-341x.2002.00171.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  38 in total

1.  Comparison of remifentanil EC50 for facilitating i-gel and laryngeal mask airway insertion with propofol anesthesia.

Authors:  Jong Bum Choi; Hyun Jeong Kwak; Kyung Cheon Lee; Se Ryeon Lee; Sook Young Lee; Jong Yeop Kim
Journal:  J Anesth       Date:  2016-01-13       Impact factor: 2.078

2.  The effect of dexmedetomidine pretreatment on the median effective bolus dose of propofol for facilitating laryngeal mask airway insertion.

Authors:  Ji Young Yoo; Hyun Jeong Kwak; Yong Beom Kim; Chu Kyung Park; Sook Young Lee; Jong Yeop Kim
Journal:  J Anesth       Date:  2016-08-29       Impact factor: 2.078

3.  Estimating the dose-toxicity curve in completed phase I studies.

Authors:  Alexia Iasonos; Irina Ostrovnaya
Journal:  Stat Med       Date:  2011-02-22       Impact factor: 2.373

4.  Bayesian hybrid dose-finding design in phase I oncology clinical trials.

Authors:  Ying Yuan; Guosheng Yin
Journal:  Stat Med       Date:  2011-03-01       Impact factor: 2.373

5.  Up-and-down designs for phase I clinical trials.

Authors:  Suyu Liu; Chunyan Cai; Jing Ning
Journal:  Contemp Clin Trials       Date:  2013-07-13       Impact factor: 2.226

6.  Adaptive Isotonic Estimation of the Minimum Effective and Peak Doses in the Presence of Covariates.

Authors:  Changfu Xiao; Anastasia Ivanova
Journal:  J Stat Plan Inference       Date:  2012-07-01       Impact factor: 1.111

7.  A modified toxicity probability interval method for dose-finding trials.

Authors:  Yuan Ji; Ping Liu; Yisheng Li; B Nebiyou Bekele
Journal:  Clin Trials       Date:  2010-10-08       Impact factor: 2.486

8.  Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials.

Authors:  Fangrong Yan; Sumithra J Mandrekar; Ying Yuan
Journal:  Clin Cancer Res       Date:  2017-05-25       Impact factor: 12.531

9.  A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials.

Authors:  Haitao Pan; Ying Yuan
Journal:  Stat Med       Date:  2016-03-16       Impact factor: 2.373

10.  An adaptive design for identifying the dose with the best efficacy/tolerability profile with application to a crossover dose-finding study.

Authors:  Anastasia Ivanova; Ken Liu; Ellen Snyder; Duane Snavely
Journal:  Stat Med       Date:  2009-10-30       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.